COVID-19: BA.2's Even More Concerning Sub-Variant, H78Y Mutation
Dr. Kevin Kavanagh from Health Watch USA^sm discusses the recent randomized controlled trial which failed to show any benefit of Ivermectin to prevent severe COVID-19. The CDC has reported immunity produced by boosters is waning after 4 months and the country of Israel is administering a fourth vaccine dose to all. In the United State a fourth dose is recommended to those with significant immunocompromise. If one has questions they should consult their doctor. An Omicron specific vaccine is expected to be available by late spring. The United States is relaxing restrictions for COVID-19. But this may not be a good time to let down our guard. The BA.2 Variant (Stealth Omicron) is ravaging Denmark and is more infectious and appears to cause more severe disease than Omicron (BA.1). In addition, a new Omicron Sub-Variant with a H78Y is even more concerning and has the potential to be even more infectious, cause more severe disease and even augment Omicron's propensity to evade immunity.  Jack Pattie Show.  Feb. 21, 2022.